Chief Medical Officer, Head of Research and Development · Nkarta, Inc. (NKTX)

David Shook

A named executive officer of Nkarta in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,900,182

Salary $489,507Stock awards $500,975

FY2023: $1,510,050

3rd of 3 named executive officers at Nkarta by FY2024 total.

3 named officers on file for Nkarta, FY2024

David Shook’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Nkarta’s whole pay program stands against its peers

  • Nkarta’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NKTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2025 (DEF 14A).

Free

Get David Shook’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Shook compensation by year

Nkarta Summary Compensation Table · all 2 fiscal years held
In US dollars, as Nkarta reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$459,800$489,507
Bonus$0$0
Stock awards$208,875$500,975
Option awards$669,625$723,122
Non-equity incentive$161,850$176,229
Pension and deferred compensation$0$0
All other$9,900$10,350
Total$1,510,050$1,900,182

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nkarta, Inc. DEF 14A filed April 21, 2025, accession 0001140361-25-014740, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Nkarta, Inc. filed document, accession 0001140361-25-014740. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2025.

$1.5M
$1.9M
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU56,000$139,440—
RSU28,125$70,031—
RSU23,421$58,318—
RSU7,500$18,675—
RSU2,500$6,225—
RSU830$2,067—
Option134,333—$2.19
Option12,500—$16.46
Option86,719—$6.01
Option26,875—$7.02
Option98—$54.89
Option1,667—$18.44

Per the Outstanding Equity Awards at Fiscal Year-End table in Nkarta, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 17 award rows shown.

Nkarta’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Paul HastingsChief Executive Officer$3,985,445
Nadir MahmoodPresident$3,336,117
David Shook · this pageChief Medical Officer, Head of Research and Development$1,900,182

The full Nkarta compensation record

free company brief

This page is one person within Nkarta's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Nkarta's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Shook's compensation dossier · One-time report. No refunds.